New Welsh Fund Will Give Quicker Access To New Drugs Than In England Or Scotland
Executive Summary
A new fund is expected to help remove uncertainties around the financing of new treatments in the future. It introduces new timelines for health boards to ensure that innovative medicines approved by NICE or the Welsh AWMSG are made available faster to eligible patients on the NHS.
You may also be interested in...
UK Accelerated Access Proposals Due Out Soon
UK proposals to promote innovation and speed access to promising new drugs could among other things prompt new payment models. The final report on the government’s Accelerated Access Review should be out by the end of the month.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.